Aurora Cannabis to buy rival creating the  world's most valuable cannabis firm.   Maricann announces plans to purchase  Swiss cannabis grower.   Greek government looking to  tackle unemployment with cannabis farming .  Germany’s insurance providers  reimburse 13,000 cannabis patients.   Aphria to supply nearly 77,000 kilos of  c  annabis to Nuuvera  .   Love Hemp launches a  new cannabis oil product  targeting Scotland.  Nuuvera signs letter of intent to  acquire GMP-certified lab  in Spain.     






     France looks to  soften laws against cannabis use  but legalisation not likely.  Germany's  medicinal cannabis market struggles  with short supply and high costs.  Italy addresses medical cannabis shortages with  imports from Canada and Germany .  Israeli cannabis industry is booming but  still no destination for exports .  Jersey hospital to prescribe  Sativex without private prescription .  German road safety officials  concerned that patients may smoke and drive .     






     Medical cannabis laws can significantly  reduce violent crime , a new study finds.  Medical cannabis in Israel  complements alternative healthcare  among its ageing population argues Raphael Mechoulam.  Cannabidiol could  reduce fall-related seizures  in treatment-resistant epilepsy   Note -  Prohibition Partners will be attending  NIMCS 2018  this coming Saturday in Belfast.     






       SERBIAN PATIENTS FIGHT FOR CANNABIS REFORM    Serbia is  the largest and most populous country of the former Yugoslavia. It is home to a strong pro-legalisation movement which is led by activists, patients and researchers. In this case, that opposing force is spearheaded by far-right parties and conservative medical groups who desperately cling to ill-informed stigmas surrounding cannabis.  As part of the Prohibition Partners  European Country Review , we examine what divides opinion on cannabis legislation and how far they have come on the bumpy road to modernisation.     












     Prohibition Partners is excited to announce the launch of Medical Cannabis in Europe. The GMP Standards Guide, in association with  Orion GMP Solutions .  If Europe wants to become global leaders in the cannabis industry, ensuring that it adheres to the highest manufacturing practices is essential. The GMP Standards Guide is intended to be used as a reference by manufacturers, legislators and all involved in the European cannabis industry to educate on best practice and international legislation.  The report is due to be released in February 2018 but you can read a short extract  here .

The world's largest cannabis merger begins to take shape as North American firms look to Europe. On home soil France looks to soften drug laws but fends off legalisation discussions and Germany and Italy struggle with shortages. This weeks country review looks at Serbian patients fights for medical cannabis. 







     Industry giants  Tilray have raised €20 million  to serve the EU medical cannabis market.  Canadian supplier Canopy  extend   their European reach  with a deal to supply cannabis seeds to Spanish pharmaceutical producer.  Cannabis biotech companies are  taking a leading stance  in the global legal marketplace.   In a rapidly growing market,  these three cannabis stocks  claim the fastest revenue growth.     






     A new  cannabis bill has been put forward  in Australia that could resonate in the UK.  Welsh MP, Paul Flynn, continues to  push for UK cannabis reform .  Israel continues to  edge closer towards  cannabis decriminalisation, with new 'four strikes' policy.      






      UK     Could   Still Dominate The European Legal Cannabis Market   Cannabis law reform has been a key talking point in British politics for many years. Yet, as the global attitude towards cannabis becomes more and more progressive, could the UK be left behind?     
	 Learn More 






     Attitudes across Europe are changing fast and, although currently illegal, we believe there is a 60%-70% probability of widespread legalisation within the next 3-5 years.   Find out more at   

Tilray raise the cash to serve EU medical markets, Canadian company Canopy Growth strike a deal with Spanish pharmaceutical centre and a new cannabis bill is discussed in Australia. As part of the Prohibition Partners Country Review we discuss whether the UK is being left behind...